doi: 10.3389/fnut.2025.1538266 Received 02 December 2024 Accepted 05 March 2025 Published 26 March 2025 Volume 12 - 2025 Edited by Michele Barone, University of Bari Aldo Moro, Italy Reviewed by Samir Giuseppe Sukkar, San Martino Hospital (IRCCS), Italy Yaseen Galali, Salahaddin University, Iraq Updates Copyright 2025 Skartun, Smith, Laupsa-Borge and Dankel
According to the CDC, over 70% of American adults are either overweight or obese, leading to a surge in interest in medically supported weight loss solutions
Pre-Workout Taking L-Carnitine 3045 minutes before exercise is the most effective timing for fat loss and energy
I've heard the term that it is less risky than staying obese, right
About the Study Study Type : Prospective, single-arm study evaluating the off-label use of GLP-1 RAs Duration : 24 months Participants : 110 adults with upper or lower extremity lymphedema (ISL Stages II and III) Primary Objective : Assess improvements in quality of life using the Lymphedema Life Impact Scale (LLIS) Secondary Objectives : Measure changes in limb volume, bioimpedance, BMI, compression use, and incidence of cellulitis Participants will receive GLP-1 RA treatment for six months, with the medication prescribed and managed by their primary healthcare provider
For individuals focused on performance and body composition , Tirzepatides dual action suggests enhanced potential for fat mass reduction while preserving lean tissue , particularly when paired with resistance training and proper nutrition